Research
Hormonal
GLP-1 receptor agonists (GLP-1 RAs) can lead to modest yet statistically significant reductions in systolic blood pressure (SBP).
GLP-1 RAs may be considered as adjunctive therapies for managing hypertension.
StrongSupportsmedium confidence
Clinical trials demonstrate modest yet statistically significant reductions in systolic blood pressure (SBP).
Why this rating
Based on clinical trials mentioned in the abstract.
Source
Impact of glucagon-like peptide-1 receptor agonists on hypertension management: a narrative review
Diana De Oliveira-Gomes et al. · Current Opinion in Cardiology · 2025
reviewCited 2×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →